Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

David W.C. Beasley; Li Li; Miguel T. Suderman; Farshad Guirakhoo; Dennis W. Trent; Thomas P. Monath; Robert E. Shope; Alan D.T. Barrett

doi:10.1016/j.vaccine.2004.03.027

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

David W.C. Beasley, Li Li, Miguel T. Suderman, Farshad Guirakhoo, Dennis W. Trent, Thomas P. Monath, Robert E. Shope, Alan D.T. Barrett

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Abstract

The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX^®, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX^® control.

Original language	English (US)
Pages (from-to)	3722-3726
Number of pages	5
Journal	Vaccine
Volume	22
Issue number	27-28
DOIs	https://doi.org/10.1016/j.vaccine.2004.03.027
State	Published - Sep 9 2004

Keywords

ChimeriVax™-JE
Genotype
Japanese encephalitis virus

ASJC Scopus subject areas

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2004.03.027

Cite this

Beasley, D. W. C., Li, L., Suderman, M. T., Guirakhoo, F., Trent, D. W., Monath, T. P., Shope, R. E., & Barrett, A. D. T. (2004). Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine. Vaccine, 22(27-28), 3722-3726. https://doi.org/10.1016/j.vaccine.2004.03.027

@article{b11a8e5b5eeb43c88b78334511b1f827,

title = "Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax{\texttrademark}-JE experimental vaccine",

abstract = "The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax{\texttrademark}-JE, and the currently licensed vaccine, JE-VAX{\textregistered}, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax{\texttrademark}-JE stimulated protection that was comparable or superior to the JE-VAX{\textregistered} control.",

keywords = "ChimeriVax{\texttrademark}-JE, Genotype, Japanese encephalitis virus",

author = "Beasley, {David W.C.} and Li Li and Suderman, {Miguel T.} and Farshad Guirakhoo and Trent, {Dennis W.} and Monath, {Thomas P.} and Shope, {Robert E.} and Barrett, {Alan D.T.}",

note = "Funding Information: This study was funded by Acambis Inc. ",

year = "2004",

month = sep,

day = "9",

doi = "10.1016/j.vaccine.2004.03.027",

language = "English (US)",

volume = "22",

pages = "3722--3726",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "27-28",

}

TY - JOUR

T1 - Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

AU - Beasley, David W.C.

AU - Li, Li

AU - Suderman, Miguel T.

AU - Guirakhoo, Farshad

AU - Trent, Dennis W.

AU - Monath, Thomas P.

AU - Shope, Robert E.

AU - Barrett, Alan D.T.

N1 - Funding Information: This study was funded by Acambis Inc.

PY - 2004/9/9

Y1 - 2004/9/9

N2 - The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX®, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX® control.

AB - The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX®, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX® control.

KW - ChimeriVax™-JE

KW - Genotype

KW - Japanese encephalitis virus

UR - http://www.scopus.com/inward/record.url?scp=4143125552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143125552&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2004.03.027

DO - 10.1016/j.vaccine.2004.03.027

M3 - Article

C2 - 15315852

AN - SCOPUS:4143125552

VL - 22

SP - 3722

EP - 3726

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 27-28

ER -

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this